查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1887178

DNA連接酶市場規模、佔有率、成長及全球產業分析：依類型、應用和地區劃分的洞察與預測（2024-2032）

DNA Ligases Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 167 Pages | 商品交期: 請詢問到貨日

價格

DNA連接酶市場成長驅動因素

全球DNA連接酶市場持續快速成長，主要受基因工程、分子診斷和新一代定序工作流程中應用不斷擴展的推動。根據最新的產業評估，該市場在2024年的價值為3.507億美元，預計到2025年將達到3.782億美元。預計到2032年將進一步成長至6.927億美元，2025年至2032年的複合年增長率將達到7.6%。基因組學、個人化醫療和基因編輯技術的快速發展也為此成長提供了支持。

2024年，北美以51.58%的市佔率引領全球市場，這得益於其強大的研究基礎設施、技術領先地位以及日益活躍的合作與收購活動。美國仍然是核心貢獻者，這得益於其先進的生物技術生態系統以及CRISPR-Cas9和相關基因編輯工具的高普及率，這些工具需要DNA連接酶來進行精確的DNA修復。

DNA連接酶在DNA複製、修復、重組和克隆中發揮核心作用。它們的應用範圍涵蓋次世代定序（NGS）文庫建構、基因合成和分子診斷。如此廣泛的應用正在推動全球需求的成長，尤其是在合成生物學、基因療法和客製化療法領域日益受到關注的推動。

市場成長驅動因素

基因編輯技術的廣闊前景是推動市場成長最強勁的動力之一。對 CRISPR-Cas9 研究投入的不斷增加，以及利用基因工程細胞進行的臨床研究的增多，正在加速對高品質 DNA 連接酶的需求。值得注意的是，KSQ Therapeutics 公司於 2024 年獲得了 FDA 對其 CRISPR-Cas9 工程化 TIL 候選藥物的批准，這凸顯了基因編輯工具在臨床應用方面的擴展。

此外，遺傳疾病的增加以及向個人化醫療的快速轉變進一步強化了對基於酶的分子工具的需求。 DNA 連接酶在治療藥物開發過程中仍然至關重要，尤其是在基於重組 DNA 和克隆技術的研究方法中。

市場限制因素與挑戰

儘管市場發展勢頭強勁，但仍面臨著一些限制因素，例如基因編輯中的脫靶效應、酶遞送系統的挑戰以及熟練分子生物學家的短缺。圍繞先進基因工程技術的複雜監管也延緩了產品的審批和商業化週期。專業連接酶的高昂成本對規模較小的研究機構，尤其是在新興經濟體，構成了額外的障礙。

機會概觀

策略合作、技術創新和區域市場擴張是關鍵的成長機會。各公司正大力投資開發適用於先進基因組學應用的高效連接酶。例如，生物技術收購旨在擴大重組酶的生產能力，例如 Fortis Life Sciences 收購 Empirical Biosciences 以增強其分子試劑產品組合。

由於研究能力的提升和生物製藥生產設施的擴張，亞太地區正成為成長最快的市場。中國對商業化 DNA 片段生產和基因組學平台的投資正在推動該地區對 DNA 連接酶的需求。

細分市場概覽

截至2024年，T4 DNA連接酶佔最大市場佔有率，這主要得益於其多功能性以及在克隆和基因工程工作流程中的廣泛應用。同時，T7 DNA連接酶市場預計將在2032年前快速成長，這主要得益於其在合成生物學和生物製藥研究領域的應用。

依應用領域劃分，基因組學和基因工程將在2024年引領市場，這主要得益於基於CRISPR的基因編輯技術和定制基因組修飾的日益普及。製藥和生物技術公司佔了終端用戶需求的大部分，這主要得益於基因治療、疫苗研發和重組DNA技術的擴展。

2032 年區域展望

  • 北美（2024 年市場規模：1.809 億美元）－憑藉強大的研發實力、基因編輯工具的高普及率以及持續的產業整合，保持領先地位。
  • 歐洲－憑藉活躍的學術研究和支持基因組學的健全監管框架，保持第二大市場規模。
  • 亞太地區－預計到 2032 年將實現最高的複合年增長率，這主要得益於生物技術投資的不斷增長。
  • 拉丁美洲、中東/非洲—預計基因組學的廣泛應用和政府主導的措施將推動成長。

主要參與者

主要參與者包括 Thermo Fisher Scientific、New England Biolabs、Takara Bio、Agilent Technologies、Promega Corporation、Bio-Rad Laboratories 和 Fortis Life Sciences，它們專注於酵素創新和擴展基因組工具包。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：主要發現

  • DNA修飾技術進展
  • 基因工程技術進展
  • 主要公司新產品發布
  • 主要產業趨勢（併購、合作等）
  • 新冠疫情對市場的影響

第五章：全球DNA連接酶市場分析、洞察與預測 （2019-2032）

  • 市場分析、洞察與預測 - 依類型劃分
    • T7 DNA
    • T4 DNA
    • 其他
  • 市場分析、洞察與預測 - 依應用劃分
    • 基因體學與基因工程
    • 藥物發現與研究
    • 其他
  • 市場分析、洞察與預測 - 依最終用戶劃分
    • 製藥和生技公司
    • 學術和研究機構
    • 其他
  • 市場分析、洞察與預測 - 依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章：北美DNA連接酶市場分析、洞察與預測，2019-2032

  • 依國家劃分
    • 美國
    • 加拿大

第七章 歐洲DNA連接酶市場分析、洞察與預測，2019-2032

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪的納維亞
    • 歐洲其他地區

第八章 亞太地區DNA連接酶市場分析、洞察與預測，2019-2032

  • 依國家/地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 東南亞
    • 亞太其他地區

第九章 拉丁美洲 DNA 連接酶市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第十章 中東與非洲 DNA 連接酶市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 海灣合作委員會 (GCC)
    • 南非
    • 其他中東和非洲國家

第十一章 競爭格局分析

  • 全球市佔率分析（2024）
  • 公司簡介
  • 賽默飛世爾科技公司
  • 新英格蘭生物實驗室
  • 丹納赫公司
  • 福蒂斯生命科學股份有限公司
  • 普羅米加公司
  • 伯樂生物實驗室
  • BioCat GmbH
  • 寶生物公司
  • 安捷倫科技公司
Product Code: FBI112712

Growth Factors of DNA ligases Market

The global DNA ligases market continues to advance rapidly due to rising applications in genetic engineering, molecular diagnostics, and next-generation sequencing workflows. According to the latest industry assessment, the market was valued at USD 350.7 million in 2024 and is projected to reach USD 378.2 million in 2025, eventually expanding to USD 692.7 million by 2032, reflecting a robust CAGR of 7.6% from 2025 to 2032. This growth is underpinned by accelerating developments in genomics, personalized medicine, and gene-editing technologies.

In 2024, North America dominated the global market with a 51.58% share, driven by strong research infrastructure, technological leadership, and a growing number of collaborations and acquisitions. The United States remains the core contributor, supported by an advanced biotechnology ecosystem and high adoption of CRISPR-Cas9 and related gene-editing tools that require DNA ligases for precise DNA repair.

DNA ligases play a central role in DNA replication, repair, recombination, and cloning. Their use extends across NGS library preparation, gene synthesis, and molecular diagnostics. This widespread applicability has triggered heightened global demand, especially with the increasing focus on synthetic biology, gene therapy, and customized therapeutics.

Market Growth Drivers

The expanding landscape of gene-editing technologies is one of the strongest market catalysts. The rising investment in CRISPR-Cas9 research, coupled with an increasing number of clinical studies involving engineered cells, is accelerating the demand for high-quality DNA ligases. Notably, in 2024, KSQ Therapeutics received FDA clearance for a CRISPR-Cas9 engineered TIL candidate, highlighting the expanding clinical adoption of gene-editing tools.

Furthermore, the growing number of genetic disorders and the rapid shift toward personalized medicine are reinforcing the need for enzyme-based molecular tools. DNA ligases remain indispensable in therapeutic development pipelines, especially in recombinant DNA and cloning-based methodologies.

Market Restraints and Challenges

Despite strong momentum, the market faces constraints such as off-target effects in gene editing, challenges in enzyme delivery systems, and shortages of skilled molecular biologists. Regulatory complexities around advanced genetic engineering technologies also slow product approvals and commercialization cycles. High costs of specialized ligase enzymes pose an additional barrier for smaller research institutions, particularly in emerging economies.

Opportunity Landscape

Strategic collaborations, technology upgrades, and regional market expansion represent significant growth opportunities. Companies are investing heavily in developing high-efficiency ligases suitable for advanced genomic applications. Examples include acquisitions in the biotechnology sector to expand recombinant enzyme production capabilities, such as Fortis Life Sciences acquiring Empirical Bioscience to strengthen its molecular reagents portfolio.

The Asia Pacific region is emerging as the fastest-growing market due to increasing research capabilities and expanding biopharmaceutical manufacturing facilities. China's investment in commercial DNA fragment production and genomics platforms is boosting regional demand for DNA ligases.

Segmentation Overview

T4 DNA Ligase represented the largest segment in 2024 due to its versatility and wide application in cloning and genetic engineering workflows. Meanwhile, the T7 DNA Ligase segment is forecast to grow rapidly through 2032, driven by applications in synthetic biology and biopharmaceutical research.

In application terms, genomics and genetic engineering dominated the market in 2024, with rising utilization in CRISPR-based editing and customized genome modifications. Pharmaceutical and biotechnology companies accounted for the majority of end-user demand as gene therapy, vaccine development, and recombinant DNA technologies continue to expand.

Regional Outlook Through 2032

  • North America (2024 value: USD 180.9 million) - Leadership driven by strong R&D, high adoption of gene-editing tools, and ongoing mergers.
  • Europe - Second-largest market due to strong academic research and robust regulatory frameworks supporting genomics.
  • Asia Pacific - Expected to register the highest CAGR through 2032 with expanding biotech investments.
  • Latin America & Middle East/Africa - Growth driven by genomics adoption and rising government initiatives.

Key Companies

Major players include Thermo Fisher Scientific, New England Biolabs, Takara Bio, Agilent Technologies, Promega Corporation, Bio-Rad Laboratories, Fortis Life Sciences, and others focusing on enzyme innovation and expanded genomic toolkits.

Segmentation By Type

  • T7 DNA
  • T4 DNA
  • Others

By Application

  • Genomics & Genetic Engineering
  • Drug Discovery & Research
  • Others

By End-user

  • Pharmaceutical and Biotechnology Companies
  • Academic & Research Institutes
  • Others

By Region

  • North America (By Type, Application, End-user, and Country)

U.S.

Canada

  • Europe (By Type, Application, End-user, and Country/Sub-region)

U.K.

Germany

France

Spain

Italy

Scandinavia

Rest of Europe

  • Asia Pacific (By Type, Application, End-user, and Country/Sub-region)

Japan

China

India

Australia

Southeast Asia

Rest of Asia Pacific

  • Latin America (By Type, Application, End-user, and Country/Sub-region)

Brazil

Mexico

Rest of Latin America

  • Middle East & Africa (By Type, Application, End-user, and Country/Sub-region)

GCC

South Africa

    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Technological Advancements in DNA Modification Techniques
  • 4.2. Technological Advancements in Genetic Engineering
  • 4.3. New Product Launches, By Key Players
  • 4.4. Key Industry Developments (Mergers, Acquisitions, Partnership, etc.)
  • 4.5. Impact of COVID-19 on the Market

5. Global DNA Ligases Market Analysis, Insights and Forecast, 2019-2032

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. T7 DNA
    • 5.1.2. T4 DNA
    • 5.1.3. Others
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Genomics & Genetic Engineering
    • 5.2.2. Drug Discovery & Research
    • 5.2.3. Others
  • 5.3. Market Analysis, Insights and Forecast - By End-user
    • 5.3.1. Pharmaceutical and Biotechnology Companies
    • 5.3.2. Academic & Research Institutes
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America DNA Ligases Market Analysis, Insights and Forecast, 2019-2032

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. T7 DNA
    • 6.1.2. T4 DNA
    • 6.1.3. Others
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Genomics & Genetic Engineering
    • 6.2.2. Drug Discovery & Research
    • 6.2.3. Others
  • 6.3. Market Analysis, Insights and Forecast - By End-user
    • 6.3.1. Pharmaceutical and Biotechnology Companies
    • 6.3.2. Academic & Research Institutes
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe DNA Ligases Market Analysis, Insights and Forecast, 2019-2032

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. T7 DNA
    • 7.1.2. T4 DNA
    • 7.1.3. Others
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Genomics & Genetic Engineering
    • 7.2.2. Drug Discovery & Research
    • 7.2.3. Others
  • 7.3. Market Analysis, Insights and Forecast - By End-user
    • 7.3.1. Pharmaceutical and Biotechnology Companies
    • 7.3.2. Academic & Research Institutes
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights, and Forecast - By Country/Sub-Region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific DNA Ligases Market Analysis, Insights and Forecast, 2019-2032

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. T7 DNA
    • 8.1.2. T4 DNA
    • 8.1.3. Others
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Genomics & Genetic Engineering
    • 8.2.2. Drug Discovery & Research
    • 8.2.3. Others
  • 8.3. Market Analysis, Insights and Forecast - By End-user
    • 8.3.1. Pharmaceutical and Biotechnology Companies
    • 8.3.2. Academic & Research Institutes
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights, and Forecast - By Country/Sub-Region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America DNA Ligases Market Analysis, Insights and Forecast, 2019-2032

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. T7 DNA
    • 9.1.2. T4 DNA
    • 9.1.3. Others
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Genomics & Genetic Engineering
    • 9.2.2. Drug Discovery & Research
    • 9.2.3. Others
  • 9.3. Market Analysis, Insights and Forecast - By End-user
    • 9.3.1. Pharmaceutical and Biotechnology Companies
    • 9.3.2. Academic & Research Institutes
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights, and Forecast - By Country/Sub-Region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East and Africa DNA Ligases Market Analysis, Insights and Forecast, 2019-2032

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. T7 DNA
    • 10.1.2. T4 DNA
    • 10.1.3. Others
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Genomics & Genetic Engineering
    • 10.2.2. Drug Discovery & Research
    • 10.2.3. Others
  • 10.3. Market Analysis, Insights and Forecast - By End-user
    • 10.3.1. Pharmaceutical and Biotechnology Companies
    • 10.3.2. Academic & Research Institutes
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights, and Forecast - By Country/Sub-Region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2024)
  • 11.2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
    • 11.2.1. Thermo Fisher Scientific Inc.
    • 11.2.2. New England Biolabs
    • 11.2.3. Danaher Corporation
    • 11.2.4. Fortis Life Sciences, LLC.
    • 11.2.5. Promega Corporation
    • 11.2.6. Bio-Rad Laboratories, Inc.
    • 11.2.7. BioCat GmbH
    • 11.2.8. Takara Bio Inc.
    • 11.2.9. Agilent Technologies, Inc.

List of Tables

  • Table 1: Global DNA Ligases Market Value Share (%), by Type, 2024 & 2032
  • Table 2: Global DNA Ligases Market Value Share (%), by Application, 2024 & 2032
  • Table 3: Global DNA Ligases Market Value Share (%), by End-user, 2024 & 2032
  • Table 4: Global DNA Ligases Market Revenue (USD million) Forecast, by Region, 2019-2032
  • Table 5: North America DNA Ligases Market Value Share (%), by Type, 2024 & 2032
  • Table 6: North America DNA Ligases Market Value Share (%), by Application, 2024 & 2032
  • Table 7: North America DNA Ligases Market Value Share (%), by End-user, 2024 & 2032
  • Table 8: North America DNA Ligases Market Revenue (USD million) Forecast, By Country, 2019-2032
  • Table 9: Europe DNA Ligases Market Value Share (%), by Type, 2024 & 2032
  • Table 10: Europe DNA Ligases Market Value Share (%), by Application, 2024 & 2032
  • Table 11: Europe DNA Ligases Market Value Share (%), by End-user, 2024 & 2032
  • Table 12: Europe DNA Ligases Market Revenue (USD million) Forecast, by Country/Sub-Region, 2019-2032
  • Table 13: Asia Pacific DNA Ligases Market Value Share (%), by Type, 2024 & 2032
  • Table 14: Asia Pacific DNA Ligases Market Value Share (%), by Application, 2024 & 2032
  • Table 15: Asia Pacific DNA Ligases Market Value Share (%), by End-user, 2024 & 2032
  • Table 16: Asia Pacific DNA Ligases Market Revenue (USD million) Forecast, By Country/Sub-Region, 2019-2032
  • Table 17: Latin America DNA Ligases Market Value Share (%), by Type, 2024 & 2032
  • Table 18: Latin America DNA Ligases Market Value Share (%), by Application, 2024 & 2032
  • Table 19: Latin America DNA Ligases Market Value Share (%), by End-user, 2024 & 2032
  • Table 20: Latin America DNA Ligases Market Revenue (USD million) Forecast, By Country/Sub-Region, 2019-2032
  • Table 21: Middle East & Africa DNA Ligases Market Value Share (%), by Type, 2024 & 2032
  • Table 22: Middle East & Africa DNA Ligases Market Value Share (%), by Application, 2024 & 2032
  • Table 23: Middle East & Africa DNA Ligases Market Value Share (%), by End-user, 2024 & 2032
  • Table 24: Middle East & Africa DNA Ligases Market Revenue (USD million) Forecast, By Country/Sub-Region, 2019-2032

List of Figures

  • Figure 1: Global DNA Ligases Market Revenue Breakdown (USD million, %) by Region, 2024 & 2032
  • Figure 2: Global DNA Ligases Market Value Share (%), by Type, 2024 & 2032
  • Figure 3: Global DNA Ligases Market Value Share (%), by Application, 2024 & 2032
  • Figure 4: Global DNA Ligases Market Value Share (%), by End-user, 2024 & 2032
  • Figure 5: Global DNA Ligases Market Value (USD million), by Region, 2024 & 2032
  • Figure 6: North America DNA Ligases Market Value Share (%), by Type, 2024 & 2032
  • Figure 7: North America DNA Ligases Market Value Share (%), by Type, 2024
  • Figure 8: North America DNA Ligases Market Value Share (%), by Application, 2024 & 2032
  • Figure 9: North America DNA Ligases Market Value Share (%), by Application, 2024
  • Figure 10: North America DNA Ligases Market Value Share (%), by End-user, 2024 & 2032
  • Figure 11: North America DNA Ligases Market Value Share (%), by End-user, 2024
  • Figure 12: North America DNA Ligases Market Value (USD million), By Country, 2024 & 2032
  • Figure 13: North America DNA Ligases Market Value Share (%), By Country, 2024
  • Figure 14: Europe DNA Ligases Market Value Share (%), by Type, 2024 & 2032
  • Figure 15: Europe DNA Ligases Market Value Share (%), by Type, 2024
  • Figure 16: Europe DNA Ligases Market Value Share (%), by Application, 2024 & 2032
  • Figure 17: Europe DNA Ligases Market Value Share (%), by Application, 2024
  • Figure 18: Europe DNA Ligases Market Value Share (%), by End-user, 2024 & 2032
  • Figure 19: Europe DNA Ligases Market Value Share (%), by End-user, 2024
  • Figure 20: Europe DNA Ligases Market Value (USD million), By Country/Sub-Region, 2024 & 2032
  • Figure 21: Europe DNA Ligases Market Value Share (%), By Country/Sub-Region, 2024
  • Figure 22: Asia Pacific DNA Ligases Market Value Share (%), by Type, 2024 & 2032
  • Figure 23: Asia Pacific DNA Ligases Market Value Share (%), by Type, 2024
  • Figure 24: Asia Pacific DNA Ligases Market Value Share (%), by Application, 2024 & 2032
  • Figure 25: Asia Pacific DNA Ligases Market Value Share (%), by Application, 2024
  • Figure 26: Asia Pacific DNA Ligases Market Value Share (%), by End-user, 2024 & 2032
  • Figure 27: Asia Pacific DNA Ligases Market Value Share (%), by End-user, 2024
  • Figure 28: Asia Pacific DNA Ligases Market Value (USD million), By Country/Sub-Region, 2024 & 2032
  • Figure 29: Asia Pacific DNA Ligases Market Value Share (%), By Country/Sub-Region, 2024
  • Figure 30: Latin America DNA Ligases Market Value Share (%), by Type, 2024 & 2032
  • Figure 31: Latin America DNA Ligases Market Value Share (%), by Type, 2024
  • Figure 32: Latin America DNA Ligases Market Value Share (%), by Application, 2024 & 2032
  • Figure 33: Latin America DNA Ligases Market Value Share (%), by Application, 2024
  • Figure 34: Latin America DNA Ligases Market Value Share (%), by End-user, 2024 & 2032
  • Figure 35: Latin America DNA Ligases Market Value Share (%), by End-user, 2024
  • Figure 36: Latin America DNA Ligases Market Value (USD million), By Country/Sub-Region, 2024 & 2032
  • Figure 37: Latin America DNA Ligases Market Value Share (%), By Country/Sub-Region, 2024
  • Figure 38: Middle East & Africa DNA Ligases Market Value Share (%), by Type, 2024 & 2032
  • Figure 39: Middle East & Africa DNA Ligases Market Value Share (%), by Type, 2024
  • Figure 40: Middle East & Africa DNA Ligases Market Value Share (%), by Application, 2024 & 2032
  • Figure 41: Middle East & Africa DNA Ligases Market Value Share (%), by Application, 2024
  • Figure 42: Middle East & Africa DNA Ligases Market Value Share (%), by End-user, 2024 & 2032
  • Figure 43: Middle East & Africa DNA Ligases Market Value Share (%), by End-user, 2024
  • Figure 44: Middle East & Africa DNA Ligases Market Value (USD million), By Country/Sub-Region, 2024 & 2032
  • Figure 45: Middle East & Africa DNA Ligases Market Value Share (%), By Country/Sub-Region, 2024